Andrea E Wahner Hendrickson, MD

  • 905 Citations
  • 15 Scopus h-Index
19982019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrea E Wahner Hendrickson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 905 Citations
  • 15 Scopus h-Index
  • 24 Article
  • 5 Review article
  • 2 Comment/debate
  • 1 Letter

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

Hurley, R. M., Wahner Hendrickson, A. E., Visscher, D. W., Ansell, P., Harrell, M. I., Wagner, J. M., Negron, V., Goergen, K. M., Maurer, M. J., Oberg, A. L., Meng, X. W., Flatten, K. S., De Jonge, M. J. A., Van Herpen, C. D., Gietema, J. A., Koornstra, R. H. T., Jager, A., den Hollander, M. W., Dudley, M., Shepherd, S. P. & 2 others, Swisher, E. M. & Kaufmann, S. H., Jan 1 2019, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

  • 4 Scopus citations

    Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer?

    Balko, R. A., Wahner Hendrickson, A. E., Grudem, M. E., Klampe, C. M. & Jatoi, A., Jan 1 2019, In : American Journal of Hospice and Palliative Medicine. 36, 1, p. 72-75 4 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Clinical Pearls in Oncology 2019

    Wahner Hendrickson, A. E. & Bundrick, J. B., Jan 1 2019, In : Disease-a-Month.

    Research output: Contribution to journalReview article

    Loratadine for Paclitaxel-Induced Myalgias and Arthralgias

    Smith, C., Wahner Hendrickson, A. E., Grudem, M., Klampe, C., Deering, E. & Jatoi, A., Jan 1 2019, (Accepted/In press) In : American Journal of Hospice and Palliative Medicine.

    Research output: Contribution to journalArticle

  • Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

    Moore, K. N., Secord, A. A., Geller, M. A., Miller, D. S., Cloven, N., Fleming, G. F., Wahner Hendrickson, A. E., Azodi, M., DiSilvestro, P., Oza, A. M., Cristea, M., Berek, J. S., Chan, J. K., Rimel, B. J., Matei, D. E., Li, Y., Sun, K., Luptakova, K., Matulonis, U. A. & Monk, B. J., May 1 2019, In : The Lancet Oncology. 20, 5, p. 636-648 13 p.

    Research output: Contribution to journalArticle

  • 21 Scopus citations